Table 2 Pathologic response at surgery
RCB class | All patients (n = 29) No. of patients (%) | Arm A (chemotherapy first) (n = 15) No. of patients (%) | Arm B (immunotherapy first) (n = 14) No of patients (%) | |||
|---|---|---|---|---|---|---|
Received neoadj AC (n = 15) | No neoadj AC (n = 14) | Received neoadj AC (n = 9) | No neoadj AC (n = 6) | Received neoadj AC (n = 6) | No neoadj AC (n = 8) | |
0 (aka pCR) | 2 (13.3%) | 3 (21.4%) | 0 (0.0%) | 2 (33.3%) | 2 (33.3%) | 1 (12.5%) |
1 | 1 (6.7%) | 2 (14.3%) | 1 (11.1%) | 1 (16.7%) | 0 (0.0%) | 1 (12.5%) |
2 | 6 (40.0%) | 4 (28.6%) | 5 (55.6%) | 1 (16.7%) | 1 (16.7%) | 3 (37.5%) |
3 | 5 (33.3%) | 5 (35.7%) | 2 (22.2%) | 2 (33.3%) | 3 (50.0%) | 3 (37.5%) |
Not evaluable* | 1 (6.7%) | 0 (0.0%) | 1 (11.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
